Installation
About
A collection of functions dedicated to simulating staggered entry platform trials whereby the treatment under investigation is a combination of two active compounds. In order to obtain approval for this combination therapy, superiority of the combination over the two active compounds and superiority of the two active compounds over placebo need to be demonstrated. A more detailed description of the design can be found in Meyer et al. doi:10.1002/pst.2194 and a manual in Meyer et al.
Key Metrics
Downloads
Yesterday | 7 +40% |
Last 7 days | 80 +74% |
Last 30 days | 255 -7% |
Last 90 days | 1.038 +11% |
Last 365 days | 3.480 -3% |